Your browser doesn't support javascript.
loading
High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine.
McNamara, Lucy A; Topaz, Nadav; Wang, Xin; Hariri, Susan; Fox, LeAnne; MacNeil, Jessica R.
Afiliação
  • McNamara LA; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC.
  • Topaz N; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC.
  • Wang X; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC.
  • Hariri S; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC.
  • Fox L; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC.
  • MacNeil JR; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC.
MMWR Morb Mortal Wkly Rep ; 66(27): 734-737, 2017 Jul 14.
Article em En | MEDLINE | ID: mdl-28704351
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Meningocócicas / Anticorpos Monoclonais Humanizados / Infecções Meningocócicas Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Meningocócicas / Anticorpos Monoclonais Humanizados / Infecções Meningocócicas Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2017 Tipo de documento: Article